SCHEMBL28360263

SCHEMBL28360263

Cc1cn(-c2c[c]c(Cl)cc2)nn1

nearest known ligand 0.42

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 9/20 0.42
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
KCNH2 Q12809 4/20 0.35
P2RX7 Q99572 1/20 0.34
FLT3 P36888 2/20 0.33
RAB9A P51151 1/20 0.33
GSK3B P49841 1/20 0.33
RXRA P19793 1/20 0.33
GRIN1 Q05586 1/20 0.33
GRIN2B Q13224 1/20 0.33
BRD4 O60885 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28357092 0.83 NOTUM (0.37) NOTUMKDM4EMAPTKCNH2P2RX7
SCHEMBL16971964 0.81 NOTUM (0.45) NOTUMKDM4EMAPTKCNH2P2RX7
SCHEMBL28360269 0.80 NOTUM (0.36) NOTUMKDM4EMAPTKCNH2P2RX7
SCHEMBL14611001 0.77 NOTUM (0.56) NOTUMKDM4EMAPTKCNH2P2RX7
SCHEMBL13183572 0.72 NOTUM (0.59) NOTUMMAPTFLT3RXRAGRIN1
SCHEMBL13183643 0.70 ESRRA (0.52) NOTUMKCNH2FLT3
SCHEMBL28949305 0.70 CYP1A2 (0.45) NOTUM
SCHEMBL12179482 0.69 MIF (0.53) NOTUMMAPT
SCHEMBL2683483 0.69 FLT3 (0.50) NOTUMFLT3RAB9ARXRAGRIN1
SCHEMBL28364004 0.69 NOTUM (0.59) NOTUM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116987080-A Macrocyclic compounds with heterocyclic P2' groups as factor XIA inhibitors 百时美施贵宝公司 2023-11-03 CN disclosed
CN-110845498-B Macrocyclic compounds having heterocyclic P2' groups as factor XIA inhibitors 百时美施贵宝公司 2023-02-17 CN disclosed
CN-110845498-A Macrocyclic compounds having a heterocyclic P2' group as factor XIA inhibitors 百时美施贵宝公司 2020-02-28 CN disclosed